ERBB2 and neoplasm: Ptpn2 knockdown enhanced the tumour antigen‐specific activation/cytotoxic potential and killing capacity of HER‐2 CAR T cells ex vivo (Fig EV5C–E) and markedly repressed the growth of HER‐2‐E0771 mammary tumours in vivo (Fig 8C).